Literature DB >> 3016049

Interaction of salivary fibronectin with oral streptococci.

J P Babu, M K Dabbous.   

Abstract

Immunoreactive Fibronectin (Fn) has been demonstrated in stimulated human parotid saliva by western blot analysis and also found to be a component of the artificial tooth pellicles derived from hydroxyapatite (HA) beads coated with parotid saliva. Saliva depleted of gelatin-binding components showed a significantly lower degree of reactivity with anti-Fn antibodies than did the control saliva when tested by and enzyme-linked immunosorbent assay (ELISA). Depletion of gelatin-binding components from saliva was also found to affect the degree of saliva-mediated aggregation of four of the seven oral streptococci tested [Streptococcus mutans strains GS-5 and OMZ 176, S. sobrinus, and S. rattus]. Similarly, the adherence of the same four micro-organisms to the artificial tooth pellicles (derived form saliva which had previously been depleted of gelatin-binding component) was significantly inhibited (37-53%) when compared with the control saliva-coated HA beads. Pre-treatment of streptococci with 100 micrograms of soluble Fn also caused a 34-57% inhibition of adherence of the same oral streptococci to saliva-treated HA beads. Quantitation of Fn in human parotid saliva showed that the amounts of immunoreactive Fn varied form 2 to 6 micrograms/mL of parotid saliva. Furthermore, the Fn from parotid saliva was found to be adsorbed onto the bacterial surfaces, as demonstrated by immunofluorescence and ELISA. The presence of Fn in parotid saliva and its ability to bind to HA beads (artificial pellicles), in conjunction with the ability of soluble Fn to inhibit the adherence of streptococcal strains to the artificial tooth pellicles, suggest that the microbial ecology of the oral cavity may, in part, be influenced by the interactions mediated by salivary fibronectin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016049     DOI: 10.1177/00220345860650081001

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  8 in total

1.  Cell surface polypeptide CshA mediates binding of Streptococcus gordonii to other oral bacteria and to immobilized fibronectin.

Authors:  R McNab; A R Holmes; J M Clarke; G W Tannock; H F Jenkinson
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

2.  A human salivary protein which promotes adhesion of Streptococcus mutans serotype c strains to hydroxyapatite.

Authors:  E Kishimoto; D I Hay; R J Gibbons
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

3.  Differentiation of salivary agglutinin-mediated adherence and aggregation of mutans streptococci by use of monoclonal antibodies against the major surface adhesin P1.

Authors:  L J Brady; D A Piacentini; P J Crowley; P C Oyston; A S Bleiweis
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

4.  Collagen mediates adhesion of Streptococcus mutans to human dentin.

Authors:  L M Switalski; W G Butcher; P C Caufield; M S Lantz
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

5.  Binding of Streptococcus mutans SR protein to human monocytes: production of tumor necrosis factor, interleukin 1, and interleukin 6.

Authors:  M Soell; F Holveck; M Schöller; R D Wachsmann; J P Klein
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

6.  Effects of fibronectin and other salivary macromolecules on the adherence of Escherichia coli to buccal epithelial cells.

Authors:  D L Hasty; W A Simpson
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

7.  Salivary-agglutinin-mediated adherence of Streptococcus mutans to early plaque bacteria.

Authors:  R J Lamont; D R Demuth; C A Davis; D Malamud; B Rosan
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

8.  A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity.

Authors:  V Pancholi; V A Fischetti
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.